Cancers, Free Full-Text

Imatinib became the standard treatment for chronic myeloid leukemia (CML) about 20 years ago, which was a major breakthrough in stabilizing the pathology and improving the quality of life of patients. However, the emergence of resistance to imatinib and other tyrosine kinase inhibitors leads researchers to characterize new therapeutic targets. Several studies have highlighted the role of histone deacetylase 6 (HDAC6) in various pathologies, including cancer. This protein effectively intervenes in cellular activities by its primarily cytoplasmic localization. In this review, we will discuss the molecular characteristics of the HDAC6 protein, as well as its overexpression in CML leukemic stem cells, which make it a promising therapeutic target for the treatment of CML.

Time trial: A prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers – topic of research paper in Clinical medicine. Download scholarly

Thoracic Cancer - Wiley Online Library

Harboring Hard and Soft Cells Lets Tumors Grow and Metastasize Simultaneously

Cancers, Free Full-Text

Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization

I Am Cancer Free! - Cancer Free Gift - Tapestry

An Introduction to Human Cancers

Pancreatic Cancer Action Network – Research, Patient Support, Resources

I Am Cancer Free - song and lyrics by ManifesTunes

Classification of biliary tract cancers established by JSHBPS: 3rd English edition｜Japanese Society of Hepato-Biliary-Pancreatic Surgery

Noninvasive detection of any-stage cancer using free glycosaminoglycans

100% Cancer Free sticker — Perch Handmade

Sotorasib for Lung Cancers with KRAS p.G12C Mutation

Remission, cancer-free, no evidence of disease: What's the difference?

Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study